학술논문

Opening New Pathways to HPV Cancer Prevention through Changes in Practice, Policy, and Partnerships
Document Type
Report
Source
Journal of the Mississippi Academy of Sciences. October, 2022, Vol. 67 Issue 4, p396, 12 p.
Subject
United States
Language
English
ISSN
0076-9436
Abstract
Introduction: In the U.S., an estimated 46,143 Human Papillomavirus (HPV)- associated cancers occur each year. (CDC, 2021;). HPV vaccination and cancer disparities exist geographically and by race and ethnicity. Cancer sites include the cervix vulva, vagina, penis, anus, and oropharynx. HPV vaccination may prevent 90% of cervical cancers if vaccinated at the recommended ages of 9-12, even without screening. Of the HPV infections that persist and evolve to cervical cancer, 80% were acquired before age 26. In 2018, across the U.S., HPV vaccination completion rates for girls and boys were the lowest in Mississippi. Lack of vaccine uptake prevents community-acquired immunity from reducing disease and death. Therefore, the goal was to create statewide partnerships to improve HPVvaccination. Methods: The American Cancer Society (ACS), the Mississippi State Department of Health (MSDH), the University of Missis sippi Medical Center (UMMC), and many statewide partners formed alliances. In 2019, a Mis s is sippi HPVRoundtable (MS-HPV-RT) was created, and the MS-HPV-RT consists of experts from multiple sectors. Priority areas include: (1) strengthening provider recommendations, (2) engage systems change, and (3) increase community knowledge. Results: In 2016, a new awareness of HPV cancer prevention developed and lead to improvements. In 2019, 1,853 more HPV vaccinations occurred in Mississippi than in 2018, a 69.2 % increase after widespread system changes. Effective 2021, Mississippi Medicaid extended coverage of vaccines in pharmacy settings, and the Mississippi Board of Dental Examiners approved new dental privileges to vaccinate and bill. State Health Officer Resolutions and Legislative endorsements created observances. Discussion: Adolescent vaccination is the key to HPV cancer prevention; however, screening remains critical to preventing HPV-related cancers. In the U.S., information is lacking on HPV vaccination programs and policies at the population level. Our study demonstrates changes in HPV vaccination practice and policies through statewide partnerships in Mississippi. KEY WORDS--Cervical Cancer, Cervical Cancer Screening, Human Papillomaviruses (HPV), Vaccination, Oral Health, Dentists.
INTRODUCTION In the U.S., an estimated 46,143 Human Papillomavirus (HPV)-associated cancers occur each year. (CDC, 2021;). In Mississippi, during 20152019, 2478 new cases of HPV- associated cancers were reported. (CDC, [...]